2-Chloro-3-methyl-6-propan-2-ylpyridine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-Chloro-3-methyl-6-propan-2-ylpyridine
• 英文别名: 2-chloro-3-methyl-6-propan-2-ylpyridine
• 化学式: C₉H₁₂ClN
• 分子量: 169.65
• InChiKey: SNLGMPNLCWMRAL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• PYRAZOLOQUINOLINONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
  申请人：SANOFI

  公开号：US20140235616A1

  公开（公告）日：2014-08-21

  The invention relates to compounds corresponding to formula (I), in which R1, R2 and R3 are as defined in Claim 1 , and also to the process for preparing them and to their therapeutic use.

  这项发明涉及与式（I）相对应的化合物，其中R1、R2和R3如权利要求1中所定义，并且还涉及它们的制备方法及其治疗用途。
• PROTEIN-TARGETING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
  申请人：BioTheryX, Inc.

  公开号：US20200369679A1

  公开（公告）日：2020-11-26

  The present disclosure provides compounds, for example, a compound of Formula (I), that modulate a protein function and/or restore protein homeostasis. The disclosure provides a method of modulating a protein-mediated disease, disorder, condition, or response. Compositions, including in combination with other therapeutic agents, are provided.

  本公开提供了化合物，例如式（I）的化合物，其调节蛋白功能和/或恢复蛋白稳态。该公开提供了一种调节蛋白介导的疾病、紊乱、状况或反应的方法。还提供了与其他治疗剂结合的组合物。
• Macrocyclic compounds for treatment of medical disorders
  申请人：Achillion Pharmaceuticals, Inc.

  公开号：US11053253B2

  公开（公告）日：2021-07-06

  Macrocyclic Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, Formula V, Formula VI, Formula VII, and Formula VIII or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

  本发明提供了大环补体因子 D 抑制剂、药物组合物及其用途以及制造工艺。所提供的化合物包括式I、式II、式III、式IV、式V、式VI、式VII和式VIII或其药学上可接受的盐、原药、同位素类似物、N-氧化物或分离异构体，可选药学上可接受的组合物。本文所述的抑制剂以因子 D 为靶点，抑制或调节补体级联。
• Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications
  申请人：BioTheryX, Inc.

  公开号：US11345712B2

  公开（公告）日：2022-05-31

  The present disclosure provides compounds, for example, a compound of Formula (I), that modulate a protein function and/or restore protein homeostasis. The disclosure provides a method of modulating a protein-mediated disease, disorder, condition, or response. Compositions, including in combination with other therapeutic agents, are provided.

  本公开提供了调节蛋白质功能和/或恢复蛋白质平衡的化合物，例如式（I）化合物。本公开提供了一种调节蛋白质介导的疾病、失调、状况或反应的方法。提供了包括与其他治疗剂组合的组合物。
• QUINOLINE DERIVATIVES AS SMO INHIBITORS
  申请人：GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.

  公开号：EP3124482B1

  公开（公告）日：2019-09-11